Estradiol Terminated Phase 3 Trials for Osteoporosis / Osteopenia Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00000430Low-Dose Hormone Replacement Therapy and Alendronate for Osteoporosis